Skip to content
Screener

Compass Therapeutics, Inc. CMPX Q1 2025 earnings

Reported May 8, 2025 · Before market open

EPS-$0.12In line
EPS estimate-$0.12

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$229.3K
EPS estimate-$0.12

FAQ

When did Compass Therapeutics, Inc. report Q1 2025 earnings?
Compass Therapeutics, Inc. (CMPX) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Compass Therapeutics, Inc.'s Q1 2025 revenue and EPS?
Compass Therapeutics, Inc. reported eps of $-0.12 for Q1 2025.
Did Compass Therapeutics, Inc. beat estimates in Q1 2025?
EPS beat the consensus estimate of $-0.12 by $0.00.
How did Compass Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 50.0% from $-0.08.
Where can I find Compass Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-002952) and the 10-Q periodic report (0001171843-25-002953) directly on SEC EDGAR. The filing index links above go to sec.gov.